IRadimed
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
43.3433.01
Price/Sales ratio
10.648.73
Earnings per Share (EPS)
$1.61$2.12

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
55.0140.9516.64322.5046.9927.38201.9161.1727.7034.7937.1827.38
Price/Sales ratio
7.209.763.696.989.736.848.7113.646.669.129.716.84
Price/Book Value ratio
5.399.653.764.897.064.754.507.904.828.378.307.06
Price/Cash Flow ratio
43.6240.3212.7647.1840.1525.7747.5150.6735.3844.4329.4125.77
Price/Free Cash Flow ratio
56.9842.0515.2362.2041.6527.0653.3554.2543.51109.6140.3827.06
Price/Earnings Growth ratio
2.610.20-11.31-3.480.040.43-2.310.100.801.04-15.060.43
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/A3.53%2.21%0.82%N/A
Profitability Indicator Ratios
Gross Profit Margin
78.25%81.51%81.06%75.86%76.30%77.11%74.32%76.64%77.44%76.50%77.13%76.30%
Operating Profit Margin
19.58%36.44%33.60%5.56%19.72%22.45%-2.38%23.47%29.31%30.55%29.90%19.72%
Pretax Profit Margin
19.27%36.82%33.70%6.04%20.35%23.47%-1.94%23.52%30.35%33.15%33.11%20.35%
Net Profit Margin
13.09%23.83%22.20%2.16%20.70%25.00%4.31%22.30%24.06%26.22%26.12%20.70%
Effective Tax Rate
32.04%35.27%34.13%64.21%-1.71%-6.49%321.92%5.19%20.72%20.91%21.11%-1.71%
Return on Assets
8.79%21.36%19.39%1.28%13.01%14.43%1.92%11.25%15.00%18.65%19.76%13.01%
Return On Equity
9.81%23.58%22.62%1.51%15.02%17.34%2.23%12.92%17.41%24.07%23.98%15.02%
Return on Capital Employed
14.57%35.59%32.56%3.67%13.72%14.20%-1.14%12.90%20.30%26.42%24.74%13.72%
Liquidity Ratios
Current Ratio
9.7311.729.338.609.4910.0612.96N/AN/AN/A9.2110.06
Quick Ratio
8.8010.908.267.578.639.4412.1610.548.513.867.819.44
Cash ratio
4.156.684.834.465.977.4210.189.086.773.046.415.97
Days of Sales Outstanding
45.7044.6342.4059.7550.4869.1152.6444.8390.8968.0553.0550.48
Days of Inventory outstanding
227.92148.93230.48275.94205.45150.76176.33160.72163.03303.79251.90205.45
Operating Cycle
273.62193.57272.89335.69255.94219.87228.98205.56253.93371.85304.95255.94
Days of Payables Outstanding
67.4562.8366.4643.0339.0941.1429.4529.2654.6344.0031.3541.14
Cash Conversion Cycle
206.17130.73206.42292.66216.84178.73199.53176.29199.29327.85273.60216.84
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/AN/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/AN/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A62.27N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A6.59N/AN/A
Company Equity Multiplier
1.111.101.161.181.151.201.151.141.161.291.121.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.160.240.280.140.240.260.180.260.180.200.330.24
Free Cash Flow / Operating Cash Flow Ratio
0.760.950.830.750.960.950.890.930.810.400.720.95
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A6.59N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A31.46N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/A97.90%76.90%134.20%N/A